C4 Therapeutics (CCCC) EBIT Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3,724.00 |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | -4,871.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,871.00 |
| Dec 31, 2025 | 51,829.00 |
| Sep 30, 2025 | -12,257.00 |
| Jun 30, 2025 | -26,239.00 |
| Mar 31, 2025 | 65,726.00 |
| Dec 31, 2024 | 41,932.00 |
| Sep 30, 2024 | 6,730.00 |
| Jun 30, 2024 | 123,162.00 |
| Mar 31, 2024 | -9,642.00 |
| Dec 31, 2023 | 19,402.00 |
| Sep 30, 2023 | 22,986.00 |
| Jun 30, 2023 | -121,226.00 |
| Mar 31, 2023 | -55,393.00 |
| Dec 31, 2022 | -126,575.00 |
| Sep 30, 2022 | -19,568.00 |
| Jun 30, 2022 | 2,816.00 |
| Mar 31, 2022 | -13,366.00 |
| Dec 31, 2021 | 15,282.00 |
| Sep 30, 2021 | -6,812.00 |
| Jun 30, 2021 | -11,382.00 |
| Mar 31, 2021 | -9,516.00 |
| Dec 31, 2020 | -10,090.00 |
| Sep 30, 2020 | -3,078.00 |